124 related articles for article (PubMed ID: 3534804)
1. Combination dihydroergotamine mesylate and heparin sodium with lidocaine HCl. Pharmacokinetics, mechanism of action, clinical efficacy, and adverse effects.
Barone JA; Raia JJ; Levy DB
Pharmacotherapy; 1986; 6(4 Pt 2):3S-11S. PubMed ID: 3534804
[TBL] [Abstract][Full Text] [Related]
2. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.
Comerota AJ; Stewart GJ; White JV
Am J Surg; 1985 Oct; 150(4A):39-44. PubMed ID: 3901791
[TBL] [Abstract][Full Text] [Related]
3. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
Comerota AJ; White JV
Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanism of the synergistic effect of heparin and dihydroergotamine.
Kakkar VV; Welzel D; Murray WJ; Malone P; Jones D
Am J Surg; 1985 Oct; 150(4A):33-8. PubMed ID: 4051120
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
[TBL] [Abstract][Full Text] [Related]
6. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial. The Multicenter Trial Committee.
JAMA; 1984 Jun; 251(22):2960-6. PubMed ID: 6371278
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic efficacy of low-dose dihydroergotamine and heparin in postoperative deep venous thrombosis following intra-abdominal operations.
J Vasc Surg; 1984 Sep; 1(5):608-16. PubMed ID: 6389909
[TBL] [Abstract][Full Text] [Related]
8. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
[TBL] [Abstract][Full Text] [Related]
9. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative changes in hemostasis by heparin/dihydroergotamine prevention].
Briel RC
Fortschr Med; 1983 May; 101(18):846-9. PubMed ID: 6862345
[TBL] [Abstract][Full Text] [Related]
11. Review of the Multicenter Trial Committee report: a prospective, randomized study on the prophylaxis of postoperative deep venous thrombosis.
Comerota AJ
Pharmacotherapy; 1986; 6(4 Pt 2):18S-22S. PubMed ID: 3534803
[TBL] [Abstract][Full Text] [Related]
12. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement.
J Bone Joint Surg Am; 1989 Feb; 71(2):311-2. PubMed ID: 2918019
[No Abstract] [Full Text] [Related]
13. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
14. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
DiSerio FJ; Sasahara AA
Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
[TBL] [Abstract][Full Text] [Related]
15. Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
Med Lett Drugs Ther; 1985 May; 27(688):45-6. PubMed ID: 3889570
[No Abstract] [Full Text] [Related]
16. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.
Kakkar VV; Stamatakis JD; Bentley PG; Lawrence D; de Haas HA; Ward VP
JAMA; 1979 Jan; 241(1):39-42. PubMed ID: 758493
[TBL] [Abstract][Full Text] [Related]
17. [Postoperative thromboembolism prophylaxis with a reduced low dose heparin fraction and dihydroergotamine in fixed combination (author's transl)].
Buttermann G; Haluszczynski I; Theisinger W; Pabst HW
MMW Munch Med Wochenschr; 1981 Jul; 123(31):1213-6. PubMed ID: 6790966
[TBL] [Abstract][Full Text] [Related]
18. Reversible vasospasm in association with the use of heparin and dihydroergotamine.
Bachner EJ; Konsens RM; Priem L; King T; Froimson AI
Clin Orthop Relat Res; 1992 Oct; (283):261-4. PubMed ID: 1395256
[TBL] [Abstract][Full Text] [Related]
19. [Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].
Rasche H; Vollmar J; Burri C; Beger HG; Kilian J; Kinzl J; Krautzberger W; Wenzke C
Langenbecks Arch Chir; 1983; 360(2):81-95. PubMed ID: 6355715
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review.
Lindblad B
Acta Chir Scand Suppl; 1988; 543():31-42. PubMed ID: 3055779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
